Overview
- 58 inspections across 57 sites are on record.
- 178 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-12-19.
At a glance
Inspections
58
Sites
57
Observations
178
Career since
Dec 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| F.H. INVESTMENTS, Inc. | 19 Dec 2025 | Human Drugs | On file |
| GenoGenix LLC | 18 Jul 2025 | Human Drugs | On file |
| Fagron, Inc | 18 Nov 2021 | Human Drugs | On file |
| R.D. Laboratories, Inc. | 27 Aug 2021 | Human Drugs | On file |
| Grand River Aseptic Manufacturing, Inc. | 2 Jul 2021 | Human Drugs | On file |
Sites inspected
F.H. INVESTMENTS, Inc.Birmingham, United States1 insp.
GenoGenix LLCBoca Raton, United States1 insp.
Fagron, IncSaint Paul, United States1 insp.
R.D. Laboratories, Inc.Washington, United States1 insp.
Grand River Aseptic Manufacturing, Inc.Grand Rapids, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Emily J Orban8 shared
Emilie Kahn6 shared
Charles L Zhou4 shared
Robert M Barbosa3 shared
Joseph A Piechocki2 shared
Constantin Y Philopoulos2 shared
Michelle L Jones2 shared
Sarah M Gauna1 shared
June P Page1 shared
Lisa R Hilliard1 shared
Full investigator report
Get the verbatim findings behind Bei Y He's 178 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site